Fifth percentile cutoffvalues for antipneumococcal polysaccharide and anti-Salmonella typhi Vi IgG describe a normal polysaccharide response

Frontiers in Immunology

Volumn 8, Issue MAY, 2017, Pages

  Schaballie, Heidi ^a   Bosch, Barbara ^a,b   Schrijvers, Rik ^c   Proesmans, Marijke ^a   Boeck, Kris De ^a   Boon, Mieke Nelly ^a   Vermeulen, François ^a   Lorent, Natalie ^a   Dillaerts, Doreen ^c   Frans, Glynis ^a   Moens, Leen ^c   Derdelinckx, Inge ^a   Peetermans, Willy ^a   Kantsø, Bjørn ^d   Jørgensen, Charlotte Svaerke ^d   Emonds, Marie Paule ^e   Bossuyt, Xavier ^a   Meyts, Isabelle ^c  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b ROCKEFELLER UNIVERSITY   (United States)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d STATENS SERUM INSTITUT   (Denmark)

^e Red Cross Flanders   (Belgium)

Author keywords

Allohemagglutinins; Pneumococcal polysaccharide vaccine; Polysaccharide antibody deficiency; Salmonella typhi Vi vaccine; Specific antibody deficiency

Indexed keywords

ANTIBODY; HEMAGGLUTININ; IMMUNOGLOBULIN G; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE; TYPHOID VACCINE;

ADOLESCENT; ADULT; AGGLUTINATION TEST; ANTIBODY RESPONSE; ARTICLE; BLOOD GROUP; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; HUMAN; INJECTION SITE REACTION; MALE; PNEUMONIA; PREDICTION; PROSPECTIVE STUDY; SEROTYPE; SKIN REDNESS; VACCINATION; VACCINATION REACTION;

EID: 85020044412     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.00546     Document Type: Article

References (37)

1. Bonilla FA, Barlan I, Chapel H, Costa-Carvalho BT, Cunningham-Rundles C, de la Morena MT, et al. International consensus document (ICON): common variable immunodeficiency disorders. J Allergy Clin Immunol Pract (2016) 4(1):38-59. doi: 10.1016/j.jaip.2015.07.025
2. Wall LA, Dimitriades VR, Sorensen RU. Specific antibody deficiencies. Immunol Allergy Clin North Am (2015) 35(4):659-70. doi:10.1016/j.iac.2015.07.003
3. Ambrosino DM, Siber GR, Chilmonczyk BA, Jernberg JB, Finberg RW. An immunodeficiency characterized by impaired antibody responses to polysaccharides. N Engl J Med (1987) 316(13):790-3. doi:10.1056/NEJM198703263161306
4. Sanders LA, Rijkers GT, Kuis W, Tenbergen-Meekes AJ, de Graeff-Meeder BR, Hiemstra I, et al. Defective antipneumococcal polysaccharide antibody response in children with recurrent respiratory tract infections. J Allergy Clin Immunol (1993) 91(1 Pt 1):110-9. doi:10.1016/0091-6749(93)90303-W
5. Boyle RJ, Le C, Balloch A, Tang ML. The clinical syndrome of specific antibody deficiency in children. Clin Exp Immunol (2006) 146(3):486-92. doi:10.1111/j.1365-2249.2006.03242.x
6. Bossuyt X, Moens L, Van Hoeyveld E, Jeurissen A, Bogaert G, Sauer K, et al. Coexistence of (partial) immune defects and risk of recurrent respiratory infections. Clin Chem (2007) 53(1):124-30. doi:10.1373/clinchem.2007.075861
7. Ruuskanen O, Nurkka A, Helminen M, Viljanen MK, Käyhty H, Kainulainen L. Specific antibody deficiency in children with recurrent respiratory infections: a controlled study with follow-up. Clin Exp Immunol (2013) 172(2):238-44. doi:10.1111/cei.12053
8. Tuerlinckx D, Vermeulen F, Pékus V, de Bilderling G, Glupczynski Y, Collet S, et al. Optimal assessment of the ability of children with recurrent respiratory tract infections to produce anti-polysaccharide antibodies. Clin Exp Immunol (2007) 149(2):295-302. doi:10.1111/j.1365-2249.2007.03409.x
9. Orange JS, Ballow M, Stiehm ER, Ballas ZK, Chinen J, De La Morena M, et al. Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the basic and clinical immunology interest section of the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol (2012) 130(3 Suppl):S1-24. doi:10.1016/j.jaci.2012.07.002
10. Wernette CM, Frasch CE, Madore D, Carlone G, Goldblatt D, Plikaytis B, et al. Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin Diagn Lab Immunol (2003) 10(4):514-9. doi:10.1128/CDLI.10.4.514-519.2003
11. Schaballie H, Wuyts G, Dillaerts D, Frans G, Moens L, Proesmans M, et al. Effect of previous vaccination with pneumococcal conjugate vaccine on pneumococcal polysaccharide vaccine antibody responses. Clin Exp Immunol (2016) 185(2):180-9. doi:10.1111/cei.12784
12. Paris K, Sorensen RU. Assessment and clinical interpretation of polysaccharide antibody responses. Ann Allergy Asthma Immunol (2007) 99(5):462-4. doi:10.1016/S1081-1206(10)60572-8
13. Sorensen RU, Leiva LE. Measurement of pneumococcal polysaccharide antibodies. J Clin Immunol (2014) 34(2):127-8. doi:10.1007/s10875-013-9977-z
14. Papadatou I, Spoulou V. Pneumococcal vaccination in high-risk individuals: are we doing it right? Clin Vaccine Immunol (2016) 23(5):388-95. doi:10.1128/CVI.00721-15
15. Ferry BL, Misbah SA, Stephens P, Sherrell Z, Lythgoe H, Bateman E, et al. Development of an anti-Salmonella typhi Vi ELISA: assessment of immunocompetence in healthy donors. Clin Exp Immunol (2004) 136(2):297-303. doi:10.1111/j.1365-2249.2004.02439.x
16. Sánchez-Ramón S, de Gracia J, García Alonso AM, Rodríguez Molina JJ, Melero J, de Andrés A, et al. Multicenter study for the evaluation of the antibody response against Salmonella typhi Vi vaccination (EMPATHY) for the diagnosis of anti-polysaccharide antibody production deficiency in patients with primary immunodeficiency. Clin Immunol (2016) 169:80-4. doi:10.1016/j.clim.2016.05.006
17. Bonilla FA, Bernstein IL, Khan DA, Ballas ZK, Chinen J, Frank MM, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol (2005) 94(5 Suppl 1):S1-63. doi:10.1016/S1081-1206(10)61142-8
18. Fried AJ, Bonilla FA. Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections. Clin Microbiol Rev (2009) 22(3):396-414. doi:10.1128/CMR.00001-09
19. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol (1999) 93(3):190-7. doi:10.1006/clim.1999.4799
20. Schaballie H, Vermeulen F, Verbinnen B, Frans G, Vermeulen E, Proesmans M, et al. Value of allohaemagglutinins in the diagnosis of a polysaccharide antibody deficiency. Clin Exp Immunol (2015) 180(2):271-9. doi:10.1111/cei.12571
21. Jeurissen A, Moens L, Raes M, Wuyts G, Willebrords L, Sauer K, et al. Laboratory diagnosis of specific antibody deficiency to pneumococcal capsular polysaccharide antigens. Clin Chem (2007) 53(3):505-10. doi:10.1373/clinchem.2006.080051
22. Concepcion N, Frasch CE. Evaluation of previously assigned antibody concentrations in pneumococcal polysaccharide reference serum 89SF by the method of cross-standardization. Clin Diagn Lab Immunol (1998) 5(2):199-204
23. Hare ND, Smith BJ, Ballas ZK. Antibody response to pneumococcal vaccination as a function of preimmunization titer. J Allergy Clin Immunol (2009) 123(1):195-200. doi:10.1016/j.jaci.2008.09.021
24. Borgers H, Moens L, Picard C, Jeurissen A, Raes M, Sauer K, et al. Laboratory diagnosis of specific antibody deficiency to pneumococcal capsular polysaccharide antigens by multiplexed bead assay. Clin Immunol (2010) 134(2):198-205. doi:10.1016/j.clim.2009.10.006
25. Lal G, Balmer P, Stanford E, Martin S, Warrington R, Borrow R. Development and validation of a non-aplex assay for the simultaneous quantitation of antibodies to nine Streptococcus pneumoniae serotypes. J Immunol Methods (2005) 296(1-2):135-47. doi:10.1016/j.jim.2004.11.006
26. Balloch A, Licciardi PV, Tang MLK. Serotype-specific anti-pneumococcal IgG and immune competence: critical differences in interpretation criteria when different methods are used. J Clin Immunol (2013) 33(2):335-41. doi:10.1007/s10875-012-9806-9
27. Whaley MJ, Rose C, Martinez J, Laher G, Sammons DL, Smith JP, et al. Interlaboratory comparison of three multiplexed bead-based immunoassays for measuring serum antibodies to pneumococcal polysaccharides. Clin Vaccine Immunol (2010) 17(5):862-9. doi:10.1128/CVI.00022-10
28. Pickering JW, Martins TB, Greer RW, Schroder MC, Astill ME, Litwin CM, et al. A multiplexed fluorescent microsphere immunoassay for antibodies to pneumococcal capsular polysaccharides. Am J Clin Pathol (2002) 117(4):589-96. doi:10.1309/LMCH-C4Q2-VFL9-3T1A
29. Go ES, Ballas ZK. Anti-pneumococcal antibody response in normal subjects: a meta-analysis. J Allergy Clin Immunol (1996) 98(1):205-15. doi:10.1016/S0091-6749(96)70244-0
30. Borgers H, Meyts I, De Boeck K, Raes M, Sauer K, Proesmans M, et al. Fold-increase in antibody titer upon vaccination with pneumococcal unconjugated polysaccharide vaccine. Clin Immunol (2012) 145(2):136-8. doi:10.1016/j.clim.2012.08.010
31. Klugman KP, Gilbertson IT, Koornhof HJ, Robbins JB, Schneerson R, Schulz D, et al. Protective activity of Vi capsular polysaccharide vaccine against typhoid fever. Lancet (1987) 2(8569):1165-9. doi:10.1016/S0140-6736(87)91316-X
32. Staats HF, Kirwan SM, Whisnant CC, Stephenson JL, Wagener DK, Majumder PP. Development of a bead immunoassay to measure Vi polysaccharide-specific serum IgG after vaccination with the Salmonella enterica serovar typhi Vi polysaccharide. Clin Vaccine Immunol (2010) 17(3):412-9. doi:10.1128/CVI.00354-09
33. Ochiai RL, Khan MI, SoofiSB, Sur D, Kanungo S, You YA, et al. Immune responses to Vi capsular polysaccharide typhoid vaccine in children 2 to 16 years old in Karachi, Pakistan, and Kolkata, India. Clin Vaccine Immunol (2014) 21(5):661-6. doi:10.1128/CVI.00791-13
34. Gupta D, Faridi MMA, Aggarwal A, Kaur I. Seroprevalence of anti Vi antibodies and immunogenicity of Typhim Vi vaccine in children. Hum Vaccin (2008) 4(4):305-8. doi:10.4161/hv.4.4.5824
35. Poolman J, Borrow R. Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines. Expert Rev Vaccines (2011) 10(3):307-22. doi:10.1586/erv.11.8
36. Parker W, Yu PB, Holzknecht ZE, Lundberg K, Buckley RH, Platt JL. Specificity and function of 'natural' antibodies in immunodeficient subjects: clues to B cell lineage and development. J Clin Immunol (1997) 17(4):311-21. doi:10.1023/A:1027378716015
37. Klein HG, Anstee DJ. Mollison's Blood Transfusion in Clinical Medicine. 11th ed. Malden, MA; Oxford: Blackwell Publishing (2006)